RMD ResMed Inc.
Healthcare$208.64+0.00%OpenMarket Cap: $30.26B
As of 2026-05-26
Valuation
P/E (TTM)
22.21
PEG
1.17
P/B
4.69
P/S
5.45
EV/EBITDA
13.97
DCF Value
$282.52
FCF Yield
5.8%
Div Yield
1.2%
Margins & Returns
Gross Margin
61.7%
Operating Margin
34.3%
Net Margin
27.4%
ROE
24.4%
ROA
17.3%
ROIC
19.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $1.43B | 62.2% | $499.8M | $398.7M | $— | $0.60 |
| Q2 null | $1.42B | 62.2% | $497.6M | $392.6M | $— | $0.60 |
| Q1 null | $1.34B | 61.5% | $446.5M | $348.5M | $— | $0.60 |
| Q4 null | $1.35B | 60.8% | $454.5M | $379.7M | $— | $0.53 |
| FY null | $5.15B | 59.4% | $1.69B | $1.40B | $— | $2.12 |
| Q3 null | $1.29B | 59.3% | $426.3M | $365.0M | $— | $0.53 |
| Q2 null | $1.28B | 58.6% | $417.2M | $344.6M | $— | $0.53 |
| Q1 null | $1.22B | 58.6% | $387.3M | $311.4M | $— | $0.53 |
| Q4 null | $1.22B | 57.6% | $381.2M | $292.2M | $— | $0.48 |
| FY null | $4.69B | 56.7% | $1.32B | $1.02B | $— | $1.92 |
| Q3 null | $1.20B | 56.9% | $374.6M | $300.5M | $— | $0.48 |
| Q2 2024 | $1.16B | 57.6% | $275.1M | $208.8M | $1.42 | $0.48 |